Početna › Akutna bifentipska leukemija › Kalifornija

Kliničke studije za Akutna bifentipska leukemija u državi Kalifornija

15 studija za Akutna bifentipska leukemija traži sudionike na lokacijama u državi Kalifornija.

Gradovi u državi Kalifornija

Službeni tekst studije (engleski)

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

City of Hope, Duarte
UC Davis, Sacramento
Stanford Health Care, Stanford

U tijeku regrutacijaFaza 1

Od 12 do 78 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT03802695

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Loma Linda University Medical Center, Loma Linda
Miller Children's and Women's Hospital Long Beach, Long Beach
UCSF Benioff Children's Hospital Oakland, Oakland
i još 4

U tijeku regrutacijaFaza 2

365 Days · Oba spola · Ažurirano 25. ruj 2026. · NCT06317662

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Kaiser Permanente Downey Medical Center, Downey
City of Hope Comprehensive Cancer Center, Duarte
Loma Linda University Medical Center, Loma Linda
i još 14

U tijeku regrutacijaFaza 3

365 Days – 25 Years · Oba spola · Ažurirano 25. kol 2026. · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Kaiser Permanente Downey Medical Center, Downey
Loma Linda University Medical Center, Loma Linda
Miller Children's and Women's Hospital Long Beach, Long Beach
i još 8

U tijeku regrutacijaFaza 1/2

Do 22 godina · Oba spola · Ažurirano 25. kol 2026. · NCT04726241

Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)

Rady Children's Hospital, San Diego

U tijeku regrutacijaFaza 2

Od 1 do 18 godina · Oba spola · Ažurirano 10. kol 2026. · NCT06390319

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

City of Hope, Duarte
Valkyrie Clinical Trials, Los Angeles

U tijeku regrutacijaFaza 1/2

Od 13 do 90 godina · Oba spola · Ažurirano 6. kol 2026. · NCT06533579

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Rady Children's Hospital, San Diego

U tijeku regrutacijaFaza 1

Od 1 do 30 godina · Oba spola · Ažurirano 3. kol 2026. · NCT06177067

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

Rady Children's Hospital, San Diego

U tijeku regrutacijaFaza 4

Od 1 do 18 godina · Oba spola · Ažurirano 14. srp 2026. · NCT06289673

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

UCLA Department of Medicine, Los Angeles

U tijeku regrutacijaFaza 2

Od 18 godina i više · Oba spola · Ažurirano 7. srp 2026. · NCT07216443

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

Stanford University, Palo Alto

U tijeku regrutacijaFaza 1

Od 18 do 70 godina · Oba spola · Ažurirano 23. lip 2026. · NCT06551584

A Study of Revumenib and Mezigdomide in People With Leukemia

City of Hope Cancer Center (Data collection only), Duarte

U tijeku regrutacijaFaza 1/2

Od 12 godina i više · Oba spola · Ažurirano 22. lip 2026. · NCT07356154

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

City of Hope, Duarte
Los Angeles Cancer Network, Los Angeles
UCLA Medical Center of Hematology/Oncology, Los Angeles
i još 1

U tijeku regrutacijaFaza 1/2

Od 12 do 95 godina · Oba spola · Ažurirano 15. tra 2026. · NCT04329728

Venetoclax Basket Trial for High Risk Hematologic Malignancies

University of California San Francisco-Benioff Children's Hospital, San Francisco

U tijeku regrutacijaFaza 1

Od 1 do 40 godina · Oba spola · Ažurirano 12. ožu 2026. · NCT05292664

Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

City of Hope Medical Center, Duarte

U tijeku regrutacijaFaza 1

Od 2 godina i više · Oba spola · Ažurirano 5. ožu 2026. · NCT06575296

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Children's Hospital Los Angeles, Los Angeles
Children's Hospital Orange County, Orange
UCSF School of Medicine, San Francisco

U tijeku regrutacijaFaza 1

Od 1 do 21 godina · Oba spola · Ažurirano 6. pro 2024. · NCT05476770

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.